dr. lopategui on the evolution of targeted therapies in nsclc
Published 4 years ago • 155 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
0:52
dr. lopategui on the evolution of molecular testing in nsclc
-
2:12
dr. pennell on the evolution of targeted treatment in nsclc
-
1:44
dr. lopategui on the implications of genomic sequencing in lung cancer
-
4:23
evolution of targeted therapy in advanced nsclc
-
3:16
dr herbst on the evolution of targeted therapies for egfr nsclc
-
4:05
the evolution of alk/ros1-targeted therapy in nsclc
-
4:55
evolution of therapy in lung cancer - 2022 program: targeted therapies forum
-
12:35
episode 1: role of quantitative radionuclide imaging in cardiac amyloidosis
-
8:09
kras nsclc: prevalence and the evolution of treatment - 2022 program: targeted therapies forum
-
1:31
dr. papadimitrakopoulou on importance of more targeted therapies in nsclc
-
1:18
dr. natale on the evolution of immunotherapy in nsclc
-
2:22
dr. pennell on the evolution of targeting her2 in lung cancer
-
4:37
emerging biomarkers in lung cancer
-
1:54
dr. langer discusses the impact of targeted therapy in nsclc
-
3:30
the cost-effectiveness of targeted therapies in nsclc
-
0:57
dr. langer on targeted therapies for locally advanced non-small cell lung cancer
-
1:45
dr. feliciano on ros1-targeted therapy in nsclc
-
1:33
dr. chaft on the rise of immunotherapy in lung cancer
-
7:44
next-generation targeted therapies in non-small cell lung cancer